BlackRock Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $9.8M | Buy |
154,664
+27,351
| +21% | +$1.73M | 0.01% | 1125 |
|
|
2016
Q3 | $8.11M | Sell |
127,313
-151
| -0.1% | -$9.61K | 0.01% | 1141 |
|
|
2016
Q2 | $9.48M | Buy |
127,464
+16,916
| +15% | +$1.26M | 0.01% | 992 |
|
|
2016
Q1 | $7.39M | Buy |
110,548
+3,202
| +3% | +$214K | 0.01% | 1112 |
|
|
2015
Q4 | $7.26M | Buy |
107,346
+628
| +0.6% | +$42.5K | 0.01% | 1130 |
|
|
2015
Q3 | $5.7M | Sell |
106,718
-1,379
| -1% | -$73.7K | 0.01% | 1293 |
|
|
2015
Q2 | $6.8M | Buy |
108,097
+4,715
| +5% | +$297K | 0.01% | 1256 |
|
|
2015
Q1 | $4.97M | Buy |
103,382
+1,718
| +2% | +$82.6K | 0.01% | 1364 |
|
|
2014
Q4 | $3.38M | Sell |
101,664
-6,362
| -6% | -$211K | ﹤0.01% | 1659 |
|
|
2014
Q3 | $3.17M | Sell |
108,026
-1,084
| -1% | -$31.8K | ﹤0.01% | 1664 |
|
|
2014
Q2 | $4.24M | Buy |
109,110
+12,047
| +12% | +$468K | 0.01% | 1509 |
|
|
2014
Q1 | $4.07M | Buy |
97,063
+734
| +0.8% | +$30.8K | 0.01% | 1511 |
|
|
2013
Q4 | $3.16M | Buy |
96,329
+15,905
| +20% | +$522K | ﹤0.01% | 1672 |
|
|
2013
Q3 | $2.17M | Buy |
80,424
+4,442
| +6% | +$120K | ﹤0.01% | 1888 |
|
|
2013
Q2 | $1.77M | Buy |
+75,982
| New | +$1.77M | ﹤0.01% | 1934 |
|